Efficient throughput method for hygroscopicity classification of active and inactive pharmaceutical ingredients by water vapor sorption analysis

Pharmaceutical Development and Technology

Volumn 18, Issue 2, 2013, Pages 348-358

  Murikipudi, Vasudha ^a   Gupta, Piyush ^a   Sihorkar, Vaibhav ^a  

^a Aurigene Discovery Technologies Limited   (India)

Author keywords

Adsorption; Desorption; Hygroscopicity; Pre formulation; Water vapor sorption

Indexed keywords

ACETYLSALICYLIC ACID; ALBENDAZOLE; ENALAPRILAT; EXCIPIENT; FAMOTIDINE; IRBESARTAN; METOPROLOL SUCCINATE; NAPROXEN; NICOTINIC ACID; NIMESULIDE; RALOXIFENE;

ANALYTIC METHOD; ARTICLE; PRIORITY JOURNAL; SOLID STATE; WATER VAPOR SORPTION ANALYSIS; WETTABILITY; X RAY DIFFRACTION;

ABSORPTION; DRUG DISCOVERY; HUMIDITY; PHARMACEUTICAL PREPARATIONS; PHASE TRANSITION; STEAM; WATER; WETTABILITY;

EID: 84872441389     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2011.618947     Document Type: Article

References (36)

1. Zografi G. States of water associated with solids. Drug Dev Ind Pharm 1988;14:1905-26
2. Kontny M, Zografi G. Sorption of water by solids. In: Brittain H, editor. Physical characterization of pharmaceutical solids. New York: Marcel Dekker; 1995.386-418
3. Reutzel-Edens S, Newman A. The physical characterization of hygroscopicity in 17 pharmaceutical solids. In: Hilfiker R, editor. Polymorphism in the pharmaceutical industry. Weinheim: Wiley-VCH; 2006. 235-58
4. Fassihi A, Persicaner P. Solid state interaction of bromazepam with poly (vinylpyrrolidone) in the presence of moisture. Int J Pharm 1987; 37:167-70 (Pubitemid 17084962)
5. Padmadisastra Y, Kennedy R, Stewart P. Solid bridge formation in sulfonamide-28 29 Emdex interactive systems. Int J Pharm 1994; 112:55-63 (Pubitemid 24292913)
6. Schmitt E, Davis CW, Long ST. Moisture-dependent crystallization of amorphous lamotrigine mesylate. J Pharm Sci 1996;85:1215-1219 (Pubitemid 26372891)
7. Koizumi N, Kouji M, Itai S. Effect of water content and temperature on the stability of lornoxicam tablets. Drug Stability 1997;1:202-8 (Pubitemid 27504342)
8. Rohrs BR, Thamann TJ, Gao P, Stelzer DJ, Bergren MS, Chao RS. Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant. Pharm Res 1999;16:1850-1856 (Pubitemid 30040701)
9. Cleaver J, Karatzas G, Louis S, Hayati I. Moisture-induced caking of boric acid powder. Powder Technol 2004; 146:93-101 (Pubitemid 39314575)
10. Listiohadi Y, Hourigan J, Sleigh R, Steele R. Properties of lactose and its caking behavior. Aust J Dairy Technol. 2005; 60:33-52 (Pubitemid 40644119)
11. Nail S. Physical and chemical stability considerations in the development and stress testing of freeze-dried pharmaceuticals. Drugs Pharm Sci 2005; 153:261-91
12. Faqih AM, Mehrotra A, Hammond SV, Muzzio FJ. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials. Int J Pharm 2007;336:338-345 (Pubitemid 46670664)
13. Sun CC. Mechanism of moisture induced variations in true density and compaction properties of microcrystalline cellulose. Int J Pharm 2008;346:93-101 (Pubitemid 350101996)
14. Newman A, Reutzel-Edens S, Zografi G. Characterization of the "hygroscopic" properties of active pharmaceutical ingredients. J Pharm Sci 2008; 97(3):1047-1059
15. Huang LF, Tong WQ. Impact of solid state properties on developability assessment of drug candidates. Adv Drug Deliv Rev 2004;56:321-334
16. Narurkar A, Purkaystha AR, Sheen P-C, Augustine MA. Hygroscopicity of Celiprolol hydrochloride polymorphs. Drug Dev Ind Pharm 1988; 14:465-74
17. Kobayashi Y, Ito S, Itai S, Yamamoto K. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int J Pharm 2000;193:137-146 (Pubitemid 30001856)
18. Kojima T, Sugano K, Onoue S, Murase N, Sato M, Kawabata Y et al. Solid form selection of zwitterionic 5-HT4 receptor agonist. Int J Pharm 2008;350:35-42
19. Aaltonen J, Allesø M, Mirza S, Koradia V, Gordon KC, Rantanen J. Solid form screening-a review. Eur J Pharm Biopharm 2009;71: 23-37
20. Katrincic LM, Sun YT, Carlton RA, Diederich AM, Mueller RL, Vogt FG. Characterization, selection, and development of an orally dosed drug polymorph from an enantiotropically related system. Int J Pharm 2009;366:1-13
21. Morris KR, Fakes MG, Thakur AB, Newman AW, Singh AK, Venit JJ, et al. An integrated approach to the selection of optimal salt form for a new drug candidate Int J. Pharm 1994; 105:209-17
22. Bastin R, Bowker M, Slater B. Salt selection and optimization procedures for pharmaceutical new chemical entities. Org Process Res Dev 2000; 4:427-435
23. Machatha SG, Sanghvi T, Yalkowsky SH. Structure determination and characterization of carbendazim hydrochloride dihydrate. AAPS PharmSciTech 2005;6:E115-E119 (Pubitemid 41644138)
24. Guerrieri P, Jarring K, Taylor L. Impact of counter ion on the chemical stability of crystalline salts of procaine. J Pharm Sci 2010; 99:3719-30
25. Kumar L, Amin A, Bansal AK. An overview of automated systems relevant in pharmaceutical salt screening. Drug Discov Today 2007;12:1046-1053 (Pubitemid 350186130)
26. Callahan J, Cleary G, Elefant M, Kaplan G, Kensler T, Nash R. Equilibrium moisture content of pharmaceutical excipients. Drug Dev Ind Pharm 1982; 8:355-69
27. Visalakshi NA, Mariappan TT, Bhutani H, Singh S. Behavior of moisture gain and equilibrium moisture contents (EMC) of various drug substances and correlation with compendial information on hygroscopicity and loss on drying. Pharm Dev Technol 2005;10:489-497 (Pubitemid 41770033)
28. Roskar R, Kmetec V. Evaluation of the moisture sorption behaviour of several excipients by BET, GAB and microcalorimetric approaches. Chem Pharm Bull 2005;53:662-665 (Pubitemid 40880259)
29. Anonymous. Characters section in monographs. European Pharmacopoeia 6, version 6.8, Section 5.11 ed2010
30. Hilfiker R, Blatter F, Raumer M. Relevance of solid-state properties for pharmaceutical products. In: Hilfiker R, ed. Polymorphism: In the Pharmaceutical Industry. Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA; 2006. 1-19
31. Petit S, Coquerel G. The amorphous state. In: Hilfiker R, editor. Polymorphism in the Pharmaceutical Industry. Weinheim: Wiley-VCH; 2006.259-285
32. Yoshinari T, Forbes RT, York P, Kawashima Y. Moisture induced polymorphic transition of mannitol and its morphological transformation. Int J Pharm 2002;247:69-77 (Pubitemid 35341140)
33. Balbach S, Korn C. Pharmaceutical evaluation of early development candidates "the 100 mg-approach". Int J Pharm 2004;275:1-12 (Pubitemid 38481515)
34. Umprayn K, Mendes R. Hygroscopicity and moisture adsorption kinetics of pharmaceutical solids: A review. Drug Dev Ind Pharm 1987; 13:653-693 (Pubitemid 17096800)
35. Jain A, Adeyeye M. Hygroscopicity, phase solubility and dissolution of various 6789 substituted sulfobutylether β-cyclodextrins (SBE) and danazol-SBE inclusion complexes. Int J Pharm 2001; 212:177-186 (Pubitemid 32119443)
36. van Drooge DJ, Hinrichs WL, Visser MR, Frijlink HW. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int J Pharm 2006;310:220-229 (Pubitemid 43287987)